|
WO2019067708A1
|
|
Method for particle size reduction
|
|
WO2019060797A1
|
|
Method for manufacture of inhalation powders
|
|
WO2019060604A1
|
|
Inhalable medicament
|
|
WO2019060595A1
|
|
Dry powder inhalable medicament comprising glycopyrronium
|
|
US2017020852A1
|
|
Inhalable medicament comprising tiotropium
|
|
KR20170103975A
|
|
A dry powder inhaler containing fluticasone propionate and salmeterol or propoate
|
|
AU2015271870A1
|
|
An inhaler comprising a tiotropium-containing-composition
|
|
ZA201507856B
|
|
An inhaler comprising a tiotropium-containing-composition
|
|
WO2016061445A1
|
|
Inhalable formulation
|
|
AU2014352793A1
|
|
An inhalable medicament
|
|
CN105636630A
|
|
Dry powder inhaler
|
